Northern Trust Corp Bio Path Holdings Inc Transaction History

Northern Trust Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.32 - $69.2 $506 - $26,572	384 Added 2.22%	17,711 $26,000
Q2 2022 Aug 12, 2022	SELL	$2.83 - $4.02 $1,180 - $1,676	-417 Reduced 2.35%	17,327 $67,000
Q1 2022 May 13, 2022	SELL	$2.99 - $4.17 $1,061 - $1,480	-355 Reduced 1.96%	17,744 $69,000
Q3 2021 Nov 15, 2021	BUY	$5.13 - $6.78 $1,821 - $2,406	355 Added 2.0%	18,099 $93,000
Q2 2021 Aug 13, 2021	BUY	$5.13 - $7.63 $91,026 - $135,386	17,744 New	17,744 $119,000

Ticker BPTH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,160,160
Market Cap $6.37M
Description
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.